Study to Evaluate the Safety and Dose-Range of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (MK-7123-012)
Clinical trial NCT00441701 · TERMINATED
Trial details
- NCT number
- NCT00441701
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-10-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.